Aimsweb Data Breach – sharing information
We are in receipt of information about a data breach affecting the Aimsweb 1.0 assessment platform used in the district prior to the 2016-17 school year. Aimsweb is owned by the Pearson Clinical Assessment company. The nationwide breach affected more than 13,000 school and university accounts with some accounts containing information on hundreds of thousands of students at those institutions. First and last names, email addresses, and dates of birth were obtained in the hack.
For Lee’s Summit School District, this breach may have affected close to ten years worth of student data – specifically 11,869 students in Lee’s Summit School District. The student data affected includes student first and last name, and in some instances, date of birth and email address. The account administrator data (LSR7 staff members) affected may include first and last name, job title, work email and work address. No grade or assessment information was affected in this incident, and the Aimsweb 1.0 platform does not contain Social Security numbers, credit card data or other financial information.
We take the security of student and staff data very seriously. All of our district contracts containing student and staff information are approved by the Board of Education and have specific language protecting that student and staff data – all per our Board policy EHBC. We have included a letter from the Pearson educational company that has further detail. As they write in their letter, Pearson is offering complimentary credit monitoring services from Experian for affected individuals. While they do not have any evidence that the information was misused, they are providing this option for those who wish to enroll as a precautionary measure. If you are interested in learning more about this option, please call 866-883-3309 or email firstname.lastname@example.org.
We felt strongly that being transparent and clear about this information breach was in the best interest of our student and staff data practices. Pearson Clinical Assessment Letter – 2019